NUVASIVE, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/35bb70f9-2864-4369-9e1f-072ddd4b360c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $1.2B | 2022-01-01 – 2022-12-31 | evidence 0001142596-23-000013 |
| FY 2021 | $1.1B | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-006269 |
| FY 2020 | $1.1B | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008934 |
| FY 2019 | $1.2B | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-005596 |
| FY 2018 | $1.1B | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-003470 |
| FY 2017 | $1.0B | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-003470 |
| FY 2016 | $962.1M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-003470 |
| FY 2015 | $811.1M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-012671 |
| FY 2014 | $762.4M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-000913 |
| FY 2013 | $685.2M | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-000913 |
| FY 2012 | $620.3M | 2012-01-01 – 2012-12-31 | evidence 0001142596-14-000004 |
| FY 2011 | $540.5M | 2011-01-01 – 2011-12-31 | evidence 0001142596-14-000004 |
| FY 2010 | $478.2M | 2010-01-01 – 2010-12-31 | evidence 0000950123-11-018857 |
| FY 2009 | $370.3M | 2009-01-01 – 2009-12-31 | evidence 0000950123-11-018857 |
| FY 2008 | $250.1M | 2008-01-01 – 2008-12-31 | evidence 0000950123-11-018857 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).